TesoRx Pharma, LLC
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 1/2a Study to Determine the Dose Response Pharmacokinetics of TSX-011 (Testosterone Undecanoate) in Hypogonadal Males (NCT03335254) | TesoRx Pharma, LLC | 2017-11-06 |
Track TesoRx Pharma, LLC automatically
Every clearance here is in the API, with alerts when new ones post.